Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice
Open Access
- 16 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Insights into Imaging
- Vol. 11 (1), 1-15
- https://doi.org/10.1186/s13244-020-00884-5
Abstract
Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies.Keywords
This publication has 108 references indexed in Scilit:
- Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?HPB Surgery, 2013
- Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinomaOncology Letters, 2013
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung CancerPLOS ONE, 2012
- Complications following 573 Percutaneous Renal Radiofrequency and Cryoablation ProceduresJournal of Vascular and Interventional Radiology, 2012
- Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat StudyJournal of Thoracic Oncology, 2011
- What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot studyThe British Journal of Radiology, 2009
- Early Detection of Local RFA Site Recurrence Using Total Liver Volume Perfusion CT: Initial ExperienceAcademic Radiology, 2009
- Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008